Eurofins Medinet is a global organisation dedicated to providing standardised, high quality, global central laboratory services to support all phases of clinical trials. With over 20 years' experience and scientific accomplishment, its laboratory testing portfolio has become one of the widest available in the biopharmaceutical industry, offering the synergy of integrating central laboratory services with bioanalytical, genomic and anti-infective services.
Eurofins Medinet supports its customers with six wholly owned, harmonised laboratories covering Europe, US and Asia. These facilities are located in Breda, Netherlands; Paris, France; Washington DC, US; Denver, US; Singapore; and Shanghai, China. When required, the company's global coverage is extended through standardised partners in locations such as India, South Africa and Latin America.
Eurofins Medinet's broad range of services comes with a full package of safety and efficacy parameters and complementary integration of bioanalytical, genomic and anti-infective services in one project. Global standard operating procedures and the deployment of standardised instruments and analytical methods enable the use of global reference intervals.
Eurofins Medinet has accreditations, certifications and endorsements complying with a wide range of pharmaceutical industry regulatory requirements, such as CAP, CLIA, ISO15189, ISO17025, GCP and GLP. The company's global coverage helps minimise sample transportation and logistics. It operates with open and proactive communication, providing a single point of contact at project and data management.
Eurofins Medinet is dedicated to investigator sites, provides logistics support and courier management, access to a real time online global database and operates a global LIMS system. Its laboratory services capabilities include:
